慢性阻塞性肺疾病合并肺动脉高压的治疗分析

目的观察辛伐他汀片治疗慢性阻塞性肺疾病(COPD)合并肺动脉高压的临床疗效。方法将63例COPD合并肺动脉高压患者随机分为辛伐他汀治疗组和对照组,对照组给予常规对症治疗,治疗组在常规治疗的基础上加用辛伐他汀片20mg,每晚一次口服治疗。结果治疗组总有效率93.7%,对照组总有效率80.6%,两组相比,治疗组比对照组患者肺功能改善更加明显。结论辛伐他汀治疗慢性阻塞性肺疾病合并肺动脉高压效果明显。

Objective To observe the clinical efficacy of simvastatin in the treatment of chronic obstructive pulmonary disease（COPD） merge patients with pulmonary hypertension. Methods 63 COPD cases with pulmonary hypertension（PAH） were divided into control group and treatment group randomLy. The control group received routine therapy alone, and the treatment group received oral simvastatin 20mg once, every night in addition to the routine therapy. Results In total treatment efficient the treatment group is 93.7% and the control group is 80.6% respectively. In improving lung function,the treatment group is more obviously. Conclusion Simvastatin can raise curative effect and improve lung function in the treatment of COPD with pulmonary hypertension.